AUPH
Aurinia Pharmaceuticals Inc
16.40$
-0.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | +205.6% | |
| – | +2.4% | -5.1% | -1.6% | +7.5% | -25.2% | +17.1% | +101.4% | -2.0% | +330.4% | +67.0% | -52.3% | |
| – | +47.5% | -57.1% | +206.7% | +61.7% | +8.1% | +135.4% | +79.0% | +3.4% | +40.3% | -30.3% | -53.5% | |
| – | -181.7% | – | +2,826.2% | -78.5% | +251.0% | -6.8% | +109.4% | -22.3% | – | – | – | |
| – | – | +20.4% | +15.6% | -453.1% | – | +122.8% | -578.6% | – | – | – | -261.2% | |
| – | -44.4% | -50.0% | +0.0% | +200.0% | +34.7% | +7,170.3% | -79.6% | -80.5% | +145.9% | -60.9% | -10.3% | |
| – | -99.8% | – | -180.1% | -99.2% | – | -2,132.5% | -34.3% | -41.6% | -88.9% | – | -183.5% | |
| – | -98.3% | +139.8% | +8,605.4% | -97.7% | +5,975.1% | -20.3% | +13.8% | -100.0% | – | – | +143.9% | |
| – | – | – | +0.0% | +0.0% | +0.0% | – | – | – | – | +19.6% | +9.6% | |
| – | -98.2% | +4,979.3% | +311.0% | -97.7% | +5,975.1% | -20.3% | +13.8% | -98.9% | -310.9% | +857.0% | +116.1% | |
| – | -181.2% | – | +271.7% | -137.8% | – | -117.9% | – | – | – | – | -109.3% | |
| – | – | – | – | – | – | – | – | – | – | – | +207.0% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.